ADA Scientific Sessions 2025 Abstract
Durable Glycemic Control and Elimination of Exogenous Insulin Use with VX-880 in Patients with Type 1 Diabetes (T1D)—VX-880-101 (FORWARD)
By Michael Roehrhoff Rickels, Piotr Witkowski, Trevor W Reichman, Show 13 more authorsCamillo Ricordi
Trial in peopleInterventions
The paper
Chicago
ADA Scientific Sessions 2025 Abstract, 20 Jun 2025
Presented at ADA Scientific Sessions 2025, oral 140-OR
